Self-administration of a novel subcutaneous bradykinin b2 receptor antagonist, icatibant, as an effective treatment option in patients with hereditary angioedema
Crossref DOI link: https://doi.org/10.1186/1710-1492-10-S2-A45
Published Online: 2014-12-18
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Santucci, Stephanie
Pham, Hoang
Harrison, Rachel
Yang, William
Article History
First Online: 18 December 2014